DENVER, Aug. 24, 2011 /PRNewswire/ -- FusionPharm Inc.
(PINKSHEETS: FSPM), an ancillary product and service provider for
the medical cannabis industry, is pleased to announce that they
have received commitments for their first 7 available GroPods
cultivation containers in the City of
Denver. The company received preliminary approval from the
City of Denver for use of their
GroPods in the licensed medical cannabis cultivation industry in
July and expects to complete construction and install the first
units by the end of the month.
"This is a very exciting time for the company as we launch
GroPods into the marketplace," said company CEO Scott Dittman. "Pre-launch interest has exceeded
our expectations and we are ramping up our production to meet the
market demand."
About FusionPharm Inc.
FusionPharm Inc. (http://www.fusionpharminc.com) provides a
focused variety of support products and ancillary services
primarily to the medical cannabis industry. More specifically,
FusionPharm provides specialty equipment such as GroPods,
financing, consulting and other industry-specific services to the
nascent medical cannabis industry.
The Company is NOT engaged in growing, harvesting, cultivation,
possession or distribution of marijuana.
Notes About Forward-Looking Statements:
Except for any historical information contained herein, the
matters discussed in this press release contain forward-looking
statements that involve risks and uncertainties, including those
described in the Company's Securities and Exchange Commission
reports and filings. Certain statements contained in this release
that are not historical facts constitute forward-looking
statements, within the meaning of the Private Securities Litigation
Reform Act of 1995, and are intended to be covered by the safe
harbors created by that Act. Reliance should not be placed on
forward-looking statements because they involve unknown risks,
uncertainties and other factors, which may cause actual results,
performance or achievements to differ materially from those
expressed or implied. Forward-looking statements may be identified
by words such as estimates, anticipates, projects, plans, expects,
intends, believes, should and similar expressions and by the
context in which they are used. Such statements are based upon
current expectations of the Company and speak only as of the date
made. The Company undertakes no obligation to update any
forward-looking statements to reflect events or circumstances after
the date on which they are made. For more information about GroPods
or any of FusionPharm Inc.'s products or services, call them at
720-458-0686 or view them on the web at
http://www.fusionpharminc.com.
SOURCE FusionPharm Inc.